Today: 20 May 2026
Blackbaud (BLKB) stock sinks 6% to start 2026 as software sector slides — what’s next
4 January 2026
2 mins read

Blackbaud (BLKB) stock sinks 6% to start 2026 as software sector slides — what’s next

NEW YORK, January 3, 2026, 21:05 ET — Market closed

  • Blackbaud shares closed down 6% on Friday, underperforming a broader software basket.
  • The pullback came as Wall Street’s first 2026 session stayed choppy despite gains in the Dow and S&P 500.
  • Focus now shifts to next week’s U.S. jobs and inflation data, plus Blackbaud’s next earnings window.

Blackbaud (BLKB) shares ended Friday down about 6% at $59.52, after opening at $63.21 and sliding as low as $59.32 as trading got underway for 2026. Volume was about 377,000 shares.

The drop outpaced the iShares Expanded Tech-Software Sector ETF — an exchange-traded fund that tracks a basket of U.S. software stocks — which fell about 2.9% in the same session.

The broader tape was mixed. The Dow and S&P 500 finished higher while the Nasdaq was essentially flat, with chipmakers lifting the market even as several heavyweight tech names fell, a Reuters market wrap showed. Charles Schwab’s head of trading and derivatives strategy Joe Mazzola described the mood as “buy the dip, sell the rip,” adding that investors have become more conscious of the valuations they are paying for some AI-linked trades. Reuters

Blackbaud sells cloud software used by nonprofits, schools and other organizations that manage fundraising, finance and related operations, the company says.

That business model can leave the stock sensitive to shifts in interest-rate expectations, because investors tend to discount future cash flows more heavily when rates stay higher for longer.

With the market closed for the weekend, the next near-term swing factor is macro. Investors are gearing up for next week’s U.S. labor-market report (due January 9) and consumer-price data (due January 13), Reuters’ “Week Ahead” column reported. The same report said fed funds futures — interest-rate contracts that reflect where traders expect the Fed’s policy rate to go — imply little chance of a cut at the late-January meeting and roughly even odds of a quarter-point cut in March. Reuters

Technically, BLKB is trading closer to its lows than its highs. The stock’s 52-week range spans $54.56 to $81.39, leaving Friday’s close within about $5 of the low.

In extended trading — the electronic session outside regular market hours — Blackbaud was little changed from the close, according to MarketBeat pricing. MarketBeat also lists Blackbaud’s next earnings date as an estimate around February 17, noting the company has not confirmed a publication date.

Before Monday’s open, traders will be watching whether software shares continue to lag after Friday’s slide, or whether the group stabilizes as liquidity returns after the holiday period.

Next week’s data slate has the potential to reset the market’s rate narrative quickly. A hotter inflation print or a stronger jobs report can push yields higher and pressure rate-sensitive growth shares, while softer readings tend to do the opposite.

Earnings season is also set to ramp up mid-month, which can shift sentiment across equity sectors even when a company has no immediate news of its own.

For Blackbaud specifically, investors will be looking for signs that demand in nonprofit and education end-markets is holding up, and for any commentary on customer retention, product uptake and operating efficiency when the company next reports.

After one trading day in 2026, BLKB is already down about 6% year to date. The next test is whether the stock can hold above its recent lows as macro headlines return to the driver’s seat.

Stock Market Today

  • Shanghai Top Numerical Control Soars 80% on Hong Kong IPO Boosted by Aerospace Demand
    May 20, 2026, 4:53 AM EDT. Shares of Shanghai Top Numerical Control Technology, a Chinese aerospace parts supplier, surged 80% on debut in Hong Kong, closing at HK$47.50. The stock opened 40% above the HK$26.39 offer price, peaking at HK$48.40 amid strong investor demand. The company raised HK$1.72 billion (US$219.6 million) from 65.33 million shares. The public tranche was oversubscribed 3,764 times, and institutional demand was 29 times oversubscribed, reflecting heightened focus on the aerospace sector. This comes amid global enthusiasm for aerospace tech, with major players like SpaceX eyeing a record IPO. China's aerospace firms also prepare listings, signaling robust market interest.

Latest articles

Chewy Shares Slide on CEO Talk of “Stretched Consumer”

Chewy Shares Slide on CEO Talk of “Stretched Consumer”

20 May 2026
Chewy Inc. shares dropped 9.1% to $19.66 Tuesday after CEO Sumit Singh warned U.S. consumers are more financially strained than earlier this year. The decline put Chewy near its 52-week low ahead of its June 10 earnings report. Singh made the comments at a J.P. Morgan conference, citing multiple data points on weaker consumer demand. Petco fell 2.9%, while BARK rose 7.5% and Amazon slipped 2.1%.
Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

20 May 2026
Meiwu Technology shares jumped 97% to $4.75 Tuesday and rose another 12% premarket after the company raised $15.65 million in a private share sale to fund an AI skincare platform. The rally follows a 1-for-100 reverse share split in April and earlier $14 million direct offering. Meiwu warned its new platform is early-stage and faces regulatory risks.
Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

20 May 2026
Astera Labs shares rose 13.3% to $244.26 on Tuesday after management outlined a faster ramp for its Scorpio X fabric switches and optical networking tied to Nvidia’s NVLink Fusion. The move followed presentations at J.P. Morgan’s tech conference and comes ahead of Nvidia’s earnings Wednesday. Astera’s first-quarter revenue jumped 93% to $308.4 million, with second-quarter guidance above analyst forecasts.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop